What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Cancer
Bernd Schnabl mainly investigates Immunology, Liver disease, Alcoholic liver disease, Cirrhosis and Fatty liver.
He combines subjects such as REG3G, Steatohepatitis and Hepatic stellate cell with his study of Immunology.
His research integrates issues of Microbiome, Liver injury, Hepatocyte, Hepatitis and Chronic liver disease in his study of Liver disease.
His research investigates the connection between Alcoholic liver disease and topics such as Dysbiosis that intersect with issues in Microbiology and Metabolome.
His work carried out in the field of Cirrhosis brings together such families of science as Nonalcoholic fatty liver disease, Decompensation and Ascites.
His study looks at the relationship between Fatty liver and fields such as Fibrosis, as well as how they intersect with chemical problems.
His most cited work include:
- Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. (767 citations)
- Interactions between the intestinal microbiome and liver diseases. (501 citations)
- Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice (494 citations)
What are the main themes of his work throughout his whole career to date?
Liver disease, Internal medicine, Immunology, Alcoholic liver disease and Cirrhosis are his primary areas of study.
His studies in Liver disease integrate themes in fields like Microbiome, Gut flora, Dysbiosis, Alcoholic hepatitis and Fatty liver.
His Internal medicine study incorporates themes from Gastroenterology and Endocrinology.
His research on Immunology often connects related areas such as Hepatic stellate cell.
His research in Alcoholic liver disease focuses on subjects like Steatohepatitis, which are connected to Proinflammatory cytokine.
Bernd Schnabl works on Cirrhosis which deals in particular with Chronic liver disease.
He most often published in these fields:
- Liver disease (74.12%)
- Internal medicine (49.02%)
- Immunology (50.20%)
What were the highlights of his more recent work (between 2018-2021)?
- Liver disease (74.12%)
- Gut flora (30.98%)
- Microbiome (38.04%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Liver disease, Gut flora, Microbiome, Alcoholic hepatitis and Immunology.
His Liver disease research integrates issues from Cirrhosis, Alcoholic liver disease, Dysbiosis and Fatty liver.
His work in the fields of Cirrhosis, such as Chronic liver disease, overlaps with other areas such as Lachnospiraceae.
His Dysbiosis study combines topics from a wide range of disciplines, such as Steatohepatitis and Intestinal permeability.
His work focuses on many connections between Microbiome and other disciplines, such as Nonalcoholic fatty liver disease, that overlap with his field of interest in Liver biopsy, FGF21, Odds ratio and Receptor.
The study incorporates disciplines such as Gastroenterology and Endocrinology in addition to Internal medicine.
Between 2018 and 2021, his most popular works were:
- Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease (143 citations)
- Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease (143 citations)
- Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease (100 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Cancer
His main research concerns Liver disease, Dysbiosis, Alcoholic hepatitis, Gut flora and Immunology.
The concepts of his Liver disease study are interwoven with issues in Alcoholic liver disease, Pathogenesis, Disease, Fatty liver and Intestinal permeability.
His studies deal with areas such as Fibrosis and Cirrhosis as well as Fatty liver.
The various areas that Bernd Schnabl examines in his Dysbiosis study include Gastroenterology and Antibiotics.
His Gut flora research includes elements of Proinflammatory cytokine and Liver injury, Pharmacology.
His Immunology research incorporates themes from Chronic liver disease, Microbiome and Hepatocyte.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
